“obesity” Archives

in
Entry Author Date Location
Some Good News, Finally, for Zafgen’s Obesity Drug 01/20/16 Boston
Pharmabros, Designer Babies, And Other Final Words For 2015 12/24/15 National
What Three Biotechs Could Tell Us About The Pfizer-Allergan Merger 12/01/15 National
After a Clinical Trial Death, Zafgen Presses On, Families Stay Calm 11/23/15 Boston
East Coast Biotech Roundup: Cancer Vaccines, Biogen, LabCentral & More 10/23/15 Boston
FDA Puts a Hold on Zafgen’s Obesity Drug, Shares Slide 10/16/15 Boston
WSU’s New IBio Center Plans Holistic Approach to Urban Health Issues 10/16/15 Detroit Ann Arbor
Breaking Silence, Zafgen Reveals Patient Died During Obesity Trial 10/14/15 Boston
Arena Pharmaceuticals’ Board Asks CEO Jack Lief to Retire 10/05/15 San Diego
Texas Roundup: DrNow, Galvanize, Orbera, Rise, HUVR, Microsoft 08/17/15 Texas
FDA Approves Apollo Endosurgery’s Gastric Balloon for Obesity 08/11/15 Texas
Metacrine Raises $36M in VC Funding, Focuses on Metabolic Diseases 08/05/15 San Diego
Biopharmaceutical Haiku, Round Two 07/06/15 Seattle
After Orexigen Gaffe, What Role for Drugs Amid Obesity Crisis? 05/26/15 National
West Coast Biotech Roundup: Orexigen, Denali, Nant, ASCO & More 05/15/15 San Diego
Intarcia, Still Private, Nabs $225M More For Diabetes Device 04/28/15 Boston
Now Biotech-Only, Atlas Reloads With $280M Fund For New Startups 04/17/15 Boston
Days After $22M Raise, Gelesis Files for IPO 04/01/15 Boston
East Coast Biotech Roundup: Hemophilia, Levin, Vertex, Semma & More 03/27/15 Boston
Gelesis Bags $22M More, Ramps Up Trials for Weight-Loss Pill 03/26/15 Boston
East Coast Biotech Roundup: Sync Project, Epizyme, Bristol & More 03/16/15 Boston
Well-Funded NGM Bio Nabs $200M To Boost Merck’s Metabolic Pipeline 02/23/15 San Francisco
East Coast Biotech Roundup: Pre-J.P. Morgan Preening Edition 01/09/15 Boston
Don’t Get Comfortable: 5 Biopharma Flashpoints to Consider in 2015 01/06/15 National
Actavis Nabs Option to Buy Rhythm Pharma’s GI Drug For Diabetics 10/22/14 Boston
West Coast Biotech Roundup: Gates, Orexigen, Medivation & More 09/12/14 Seattle
After Prolonged Review, FDA Approves Orexigen’s Weight-Loss Drug 09/10/14 San Diego
Seres Makes Push for First Drug, and IPO, of Microbiome Era 07/16/14 Boston
Who Needs Biotech VCs, Anyway? 07/15/14 San Francisco
Zafgen Hauls In $96M in Upsized IPO 06/18/14 Boston
Page 1 of 7 next page »